share_log

Stephens & Co. Maintains Equal-Weight on Anika Therapeutics, Lowers Price Target to $23

Stephens & Co. Maintains Equal-Weight on Anika Therapeutics, Lowers Price Target to $23

Stephens & Co.Anika Therapeutics保持同等權重,將目標股價下調至23美元
Benzinga ·  2023/08/10 10:16

Stephens & Co. analyst George Sellers maintains Anika Therapeutics (NASDAQ:ANIK) with a Equal-Weight and lowers the price target from $28 to $23.

Stephens&Co.分析師George Sellers堅持Anika Treateutics(納斯達克:ANIK)的同等權重,並將目標價從28美元下調至23美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論